- Presentations
- 2
- Markets
- 1
Cimzia is a brand of Certolizumab pegol marketed by UCB, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Certolizumab pegol
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 200 mg/1 mL injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cimzia 200 mg/1 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
| Cimzia kit Cold chain | UCB | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cimzia
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.